Elafibranor

ATC A05AX06 · 7 markets · 9 records

Elafibranor 7 markets · 9 records Forms

AU 3 records · 2 strengths

80 mgtabletIQIRVO+1IQIRVO elafibranor 80 mg film-coated tablets bottle also in US·GB·CA +2 unknown

Records without a stated strength · 1 IQIRVO

US 1 records · 1 strengths

80 mgtabletIQIRVO also in AU·GB·CA +2

GB 1 records · 1 strengths

80 mgtabletIQIRVO also in AU·US·CA +2

CA 1 records · 1 strengths

80 mgtabletIQIRVO also in AU·US·GB +2

SG 1 records · 1 strengths

80 mgtabletIQIRVO also in AU·US·GB +2

ES 1 records · 1 strengths

80 mgtabletIQIRVO also in AU·US·GB +2

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 IQIRVO

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	EU
80 mg tablet	IQIRVO	IQIRVO	IQIRVO	IQIRVO IQIRVO elafibranor 80 mg film-coated tablets bottle	IQIRVO	IQIRVO	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	IQIRVO	not recorded	not recorded	IQIRVO

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.